NCBI January 22, 2019
Lloyd JT, Maresh S, Powers CA, Shrank WH, Alley DE

Abstract

BACKGROUND:

Medication adherence is associated with lower health care utilization and savings in specific patient populations; however, few empirical estimates exist at the population level.

OBJECTIVE:

The main objective of this study was to apply a data-driven approach to obtain population-level estimates of the impact of medication nonadherence among Medicare beneficiaries with chronic conditions.

RESEARCH DESIGN:

Medicare fee-for-service (FFS) claims data were used to calculate the prevalence of medication nonadherence among individuals with diabetes, heart failure, hypertension, and hyperlipidemia. Per person estimates of avoidable health care utilization and spending associated with medication adherence, adjusted for healthy adherer effects, from prior literature were applied to the number of nonadherent Medicare beneficiaries.

SUBJECTS:

A 20% random sample of community-dwelling, continuously...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Market Research, Patient / Consumer, Pharma, Pricing / Spending, Provider, Trends
Former Bristol Myers CEO tapped as Novartis’ next board chair
The Power of Drug Discovery with Philip Tagari
Novartis raises forecasts as top drug sales beat Wall Street estimates
Pharma Pulse 4/23/24: Drug Discount Programs Poised to Change with New Tech, SpecialtyRx Savings Navigator to Enhance Affordability & more
Boehringer Ingelheim Strikes Regenerative Med R&D Deal Spanning MASH & More Liver Diseases

Share This Article